Stay updated on Tezepelumab in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Tezepelumab in Atopic Dermatitis Clinical Trial page.

Latest updates to the Tezepelumab in Atopic Dermatitis Clinical Trial page
- Check6 days agoChange DetectedLocations added across the US, Australia, Canada, and Europe, and several locations removed. This affects where the study is conducted and how participants can reach sites.SummaryDifference2%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedRevision: v3.3.2 is now shown and Revision: v3.3.1 is removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check35 days agoChange DetectedRevision label updated to v3.3.1 and removal of v3.2.0; this is a superficial update to the page version indicator and does not affect study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check42 days agoChange DetectedRemoved the generic government funding operating-status notice from the page; this notice is not part of the study details and its removal does not affect the study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check56 days agoChange DetectedNo substantive updates to the study details, eligibility criteria, or locations were detected between the two screenshots; the page content remains consistent with NCT03809663. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check85 days agoChange DetectedAdded a prominent operating-status notice and a new version tag (v3.2.0), replacing the old version (v3.0.2).SummaryDifference2%

Stay in the know with updates to Tezepelumab in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tezepelumab in Atopic Dermatitis Clinical Trial page.